MyFinsight
Home
Blog
About
Contact
Net loss
$35,731K
Repayment of loan
principal
-$3,913K
Proceeds from issuance of
common stock under...
$232K
Accounts payable,
accrued and other...
$3,908K
Amortization of premiums and
discounts on marketable...
-$1,769K
Operating lease assets and
liabilities
-$1,098K
Prepaid expenses and
other current assets
-$1,042K
Net cash used in
operating activities
$32,370K
Net cash provided by
(used in) financing...
$4,145K
Canceled cashflow
$11,015K
Net decrease in cash
and cash...
-$2,835K
Canceled cashflow
$36,515K
something is missing
$42,631K
Proceeds from sale of
nonfinancial asset
$1,000K
Proceeds from sale of
fixed assets
$520K
Purchases of property and
equipment
-$8K
Stock-based compensation
-$6,683K
Other assets
$2,415K
Gain on sale of
nonfinancial asset
$1,000K
Depreciation and
amortization
-$674K
Amortization of debt discount
and issuance costs...
-$238K
Gain on disposition
of fixed assets
$5K
Net cash provided by
investing activities
-$39,322K
Canceled cashflow
$44,159K
Effect of exchange rate
changes on cash and cash...
-$28K
Maturities of marketable
securities
-$83,481K
Back
Back
Cash Flow
Kezar Life Sciences, Inc. (KZR)
Kezar Life Sciences, Inc. (KZR)
source: myfinsight.com